Sugi Predict

Sugi Predict / Compounds / SCHEMBL8001996

SCHEMBL8001996

SCHEMBL8001996

Cc1nccn1-c1ccc(-c2nc(-c3ccccn3)n(C)c2Sc2ccc(Cl)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.64
▸ GRM5 P41594 2/20 0.42
▸ GAA P10253 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ PPP1CA P62136 1/20 0.37
▸ MAPKAPK2 P49137 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BRD2 P25440 1/20 0.35
▸ BRD3 Q15059 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ADH5 P11766 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ DCTPP1 Q9H773 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993064 0.90 FAAH (0.76) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL8008516 0.86 FAAH (0.71) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL7994178 0.86 FAAH (0.66) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL8002399 0.85 FAAH (0.62) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL1303609 0.85 FAAH (0.62) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL1303678 0.85 FAAH (0.69) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL1303133 0.85 FAAH (0.69) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL1303197 0.85 FAAH (0.69) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL8003074 0.85 FAAH (0.61) FAAHGRM5GAASMN1; SMN2LMNA
SCHEMBL8005185 0.85 FAAH (0.61) FAAHGRM5GAASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 — — US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 — — US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 — — US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 — — US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885GAA 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.